Cepheid (NASDAQ:CPHD)
| CAPS Rating |
|
|---|---|
| Open | $42.13 |
| Previous Close | $42.39 |
| Daily Range | $40.52 - $42.38 |
| 52-Week Range | $24.47 - $45.00 |
| Market Cap | $2.64B |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 663,172 |
| Average Daily Volume | 0 |
CPHD
VS S&P 500 (SPY)
How do you think CPHD will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
CPHD Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
CPHD News and Commentary
- Cepheid Increases Sales but Misses Estimates on Earnings – The Motley Fool
- Cepheid Tops Estimates - Analyst Blog – NASDAQ
- Cepheid Shares Popped: What You Need to Know – The Motley Fool
- US STOCK FUTURES: HOT STOCKS TO WATCH – SmartMoney
- US STOCK FUTURES: HOT STOCKS TO WATCH – SmartMoney
- Genomic's Useful Colon Cancer Test - Analyst Blog – NASDAQ
- Tech Stocks: 2012's Top Consumer Tech Gadgets – The Motley Fool
- Amass a Fortune With These Stocks – The Motley Fool
- Genomic Looks to Diversify Offering (revised) - Analyst Blog – NASDAQ
- Genomic Looks to Diversify Offering - Analyst Blog – NASDAQ
- Cepheid Stays Neutral - Analyst Blog – NASDAQ
- Cepheid Shines With These 2 Metrics – The Motley Fool
- Genomic DCIS Score Coming Shortly - Analyst Blog – NASDAQ
- Helical Port October Update – Blog at The Motley Fool
- Luminex Passes This Key Test – The Motley Fool
- Cepheid Seems Solid With These 2 Metrics – The Motley Fool
- Why Bio-Rad Laboratories May Be About to Take Off – The Motley Fool
- Here's Why Luminex's Earnings Are Worse Than They Look – The Motley Fool
- 5 of Last Week's Biggest Winners – The Motley Fool
- Friday's Top Performing Small Cap Stocks (CPHD, ATHN, RRR, PIP, LSCC) – NASDAQ
RSS Headlines
Fool UK
